Hepatitis C Therapy - Enzo Biochem Reports Second Quarter Results HIV-1 Stealth Vector

Enzo Biochem Reports Second Quarter Results HIV-1 Stealth Vector
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, today announced operating results for the three and six